You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemias and Myelodysplastic Syndromes

Showing 1 - 25 of 3,296
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemias, MDS Trial in Houston (sapacitabine)

Completed
  • Leukemias
  • Myelodysplastic Syndromes
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Dec 7, 2021

Leukemia, Acute, AML, Adult, ALL, Adult Trial in Charlottesville (Palliative Care Visits)

Recruiting
  • Leukemia, Acute
  • +3 more
  • Palliative Care Visits
  • Charlottesville, Virginia
    University of Virginia
Apr 28, 2022

Leukemia, Myelodysplastic Syndrome(MDS) Trial in Duarte, Houston (fadraciclib)

Recruiting
  • Leukemia
  • Myelodysplastic Syndrome(MDS)
  • Duarte, California
  • +1 more
Apr 1, 2022

Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

Active, not recruiting
  • Acute Leukemia
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

National Longitudinal Cohort of Hematological Diseases

Recruiting
  • Multiple Myeloma
  • +17 more
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jan 11, 2022

    MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)

    Recruiting
    • Myelodysplastic Syndromes
    • IV Decitabine
    • +2 more
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital,Zhejiang University School of Medi
    Oct 23, 2023

    Lower Risk MDS Per IPSS-R Trial (Luspatercept)

    Not yet recruiting
    • Lower Risk MDS Per IPSS-R
    • (no location specified)
    Jun 21, 2023

    MDS, Ferroptosis Trial in Pessac (Biological sampling)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Ferroptosis
    • Biological sampling
    • Pessac, France
    • +2 more
    Jun 19, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    MDS Trial in Houston (Luspatercept)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 2, 2023

    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)

    Recruiting
    • Acute Leukemia
    • +24 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Nov 4, 2021

    MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 30, 2023

    AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

    Not yet recruiting
    • AML/MDS
    • +2 more
    • (no location specified)
    Aug 14, 2023

    MDS Trial (Imetelstat)

    Available
    • Myelodysplastic Syndromes
    • (no location specified)
    Jun 30, 2023

    Anemia Trial (Luspatercept)

    Not yet recruiting
    • Anemia
    • Luspatercept
    • (no location specified)
    May 26, 2023

    MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • IFN-γ (interferon gamma-1b) injection
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 5, 2023

    MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    MDS Trial (Decitabine/Cedazuridine, Magrolimab)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • (no location specified)
    Apr 18, 2023

    Biospecimen Acquisition for Myelodysplastic Syndromes

    Recruiting
    • Myelodysplastic Syndromes
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022

      Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

      Recruiting
      • Iron Deficiency Anemia
      • Adelaide, South Australia, Australia
      • +8 more
      Jun 23, 2023

      Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome

      Recruiting
      • Myelodysplastic Syndromes
      • Blood test
      • Jerusalem, Israel
        Shaare Zedek Medical Center
      Nov 27, 2023

      Untreated Myelodysplastic Syndrome Trial in France (Onureg + Venetoclax)

      Not yet recruiting
      • Untreated Myelodysplastic Syndrome
      • Onureg + Venetoclax
      • Angers, France
      • +9 more
      Mar 13, 2023

      Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Rochester, Minnesota
      • +1 more
      Feb 15, 2023

      MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

      Terminated
      • MDS
      • Myelodysplastic Syndromes
      • APR-548 + Azacitidine
      • Tampa, Florida
      • +3 more
      Jul 20, 2022